ABO-401 Gene Therapy Shows Potential to Restore CFTR Function in Preclinical Study
Abeona Therapeutics' gene therapy ABO-401 successfully delivered a functional version of the CFTR gene to the lungs of mice with CF, preclinical data show.
1 Comment